Karyopharm Therapeutics Inc. (KPTI)
NASDAQ: KPTI · IEX Real-Time Price · USD
0.890
-0.027 (-3.00%)
At close: Jul 19, 2024, 4:00 PM
0.900
+0.010 (1.16%)
Pre-market: Jul 22, 2024, 7:07 AM EDT
Karyopharm Therapeutics Market Cap
Karyopharm Therapeutics has a market cap or net worth of $110.91 million as of July 22, 2024. Its market cap has decreased by -36.00% in one year.
Market Cap
110.91M
Enterprise Value
138.00M
1-Year Change
-36.00%
Ranking
Category
Stock Price
$0.89
Market Cap Chart
Since November 6, 2013, Karyopharm Therapeutics's market cap has decreased from $442.90M to $110.91M, a decrease of -74.96%. That is a compound annual growth rate of -12.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 104.80M | 5.75% |
| Dec 29, 2023 | 99.10M | -64.08% |
| Dec 30, 2022 | 275.90M | -43.21% |
| Dec 31, 2021 | 485.80M | -57.36% |
| Dec 31, 2020 | 1.14B | -5.35% |
| Dec 31, 2019 | 1.20B | 111.62% |
| Dec 31, 2018 | 568.80M | 25.59% |
| Dec 29, 2017 | 452.90M | 16.82% |
| Dec 30, 2016 | 387.70M | -18.12% |
| Dec 31, 2015 | 473.50M | -61.32% |
| Dec 31, 2014 | 1.22B | 79.50% |
| Dec 31, 2013 | 681.90M | 53.96% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| FONAR | 115.17M |
| RAPT Therapeutics | 114.83M |
| TELA Bio | 114.15M |
| aTyr Pharma | 113.18M |
| Telomir Pharmaceuticals | 111.04M |
| Adagene | 110.74M |
| Augmedix | 110.67M |
| I-Mab | 110.14M |